Stockscreener 앱 받기
0.4366
1.87%
-0.0083
시간 외 거래:
.44
0.0034
+0.78%
전일 마감가:
$0.4449
열려 있는:
$0.44
하루 거래량:
719.71K
Relative Volume:
0.13
시가총액:
$66.96M
수익:
$3,000
순이익/손실:
$-122.20M
주가수익비율:
-0.1922
EPS:
-2.272
순현금흐름:
$-86.81M
1주 성능:
-7.01%
1개월 성능:
-5.42%
6개월 성능:
-55.83%
1년 성능:
-65.35%
1일 변동 폭
$0.4292
$0.4441
1주일 범위
$0.4292
$0.48
52주 변동 폭
$0.3772
$3.03
Fractyl Health Inc Stock (GUTS) Company Profile
명칭
Fractyl Health Inc
전화
781-902-8800
주소
3 VAN DE GRAAFF DRIVE, BURLINGTON
Compare GUTS vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GUTS
Fractyl Health Inc
|
0.4366 | 68.24M | 3,000 | -122.20M | -86.81M | -2.272 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
Fractyl Health Inc Stock (GUTS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-30 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2025-09-15 | 개시 | H.C. Wainwright | Buy |
| 2025-08-28 | 개시 | Ladenburg Thalmann | Buy |
| 2024-02-28 | 개시 | Evercore ISI | Outperform |
| 2024-02-27 | 개시 | BofA Securities | Buy |
| 2024-02-27 | 개시 | Morgan Stanley | Overweight |
모두보기
Fractyl Health Inc 주식(GUTS)의 최신 뉴스
Fractyl Health Receives Nasdaq Minimum Bid Price Notice - The Globe and Mail
Fractyl Health, Inc. (GUTS) loses 77.6% in 4 weeks, here's why a trend reversal may be around the corner - MSN
Fractyl Health (Nasdaq: GUTS) faces Nasdaq minimum bid-price warning - Stock Titan
Portfolio Shifts: Is Fractyl Health Inc undervalued by DCF analysis2026 Chart Watch & Free Safe Capital Growth Stock Tips - baoquankhu1.vn
Fractyl Health to report fourth quarter and full year 2025 financial results and provide business updates on March 24, 2026 - marketscreener.com
Fractyl Health To Report Fourth Quarter And Full Year 2025 Financial Results And Provide Business Updates On March 24, 2026 - TradingView
Fractyl Health to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Updates on March 24, 2026 - The Manila Times
Fractyl Health sets March 24 call on 2025 results, business updates - Stock Titan
Investment Report: What is the dividend yield of Fractyl Health Inc2026 Valuation Update & Growth Oriented Trade Recommendations - baoquankhu1.vn
Fractyl Health, Inc. (GUTS) moves to buy: Rationale behind the upgrade - MSN
Fractyl Health, Inc. (GUTS) Initiates Purchase: Reasons for the Rating Increase - Bitget
Rosalind Advisors Inc. Takes Position in Fractyl Health, Inc. $GUTS - MarketBeat
Does Fractyl Health Inc have pricing powerMarket Growth Review & Low Risk High Win Rate Stock Picks - baoquankhu1.vn
Fractyl Health announces proposed public offering - MSN
Aug Reactions: What is the dividend yield of Fractyl Health IncWeekly Stock Recap & Expert Curated Trade Setup Alerts - baoquankhu1.vn
Fractyl Health, Inc. (NASDAQ:GUTS) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
GUTS Technical Analysis & ETF Price Forecast - Intellectia AI
GUTS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Fractyl Health Inc expected to post a loss of 18 cents a shareEarnings Preview - TradingView
Analysts Offer Insights on Healthcare Companies: Fractyl Health, Inc. (GUTS), Ionis Pharmaceuticals (IONS) and Axsome Therapeutics (AXSM) - The Globe and Mail
Fractyl Health completes randomization in Remain-1 pivotal cohort of Revita® - marketscreener.com
Fractyl Completes Randomization in REMAIN-1 Revita Trial - TipRanks
Fractyl Health Completes Randomization In Remain-1 Pivotal Cohort Of Revita® - TradingView
Fractyl Health completes randomization in REMAIN-1; topline 6-month data due early Q4 2026 - TradingView
Fractyl Health (GUTS) hits Revita pivotal trial milestone, eyes 2026 FDA filing - Stock Titan
Fractyl Health Completes Randomization in REMAIN-1 Pivotal Cohort of Revita® for Post-GLP-1 Weight Maintenance - GlobeNewswire
Fractyl Health Completes Randomization in REMAIN-1 Pivotal Cohort of Revita for Post-GLP-1 Weight Maintenance - Bitget
GUTS SEC FilingsFractyl Health 10-K, 10-Q, 8-K Forms - Stock Titan
Fractyl Health, Inc. (GUTS) Loses 77.6% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Finviz
Fractyl Health (GUTS) Projected to Post Quarterly Earnings on Monday - MarketBeat
Should I buy Fractyl Health, Inc. (GUTS) - Zacks Investment Research
GUTSFractyl Health Latest Stock News & Market Updates - Stock Titan
What is the PEG ratio of Fractyl Health Inc.July 2025 Technicals & Expert-Curated Trade Recommendations - mfd.ru
Alyeska discloses 4.97% Fractyl Health (GUTS) stake in ownership filing - Stock Titan
Fractyl Health plummets on data for Revita for weight loss maintenance - MSN
Short Interest in Fractyl Health, Inc. (NASDAQ:GUTS) Increases By 22.6% - MarketBeat
Insider Sell: What is the dividend yield of Fractyl Health IncJuly 2025 Final Week & AI Driven Price Predictions - baoquankhu1.vn
Decliners Report: How correlated is Fractyl Health Inc to the S P5002025 Momentum Check & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn
Aug Technicals: Does Fractyl Health Inc have pricing powerJuly 2025 EndofMonth & Long Hold Capital Preservation Plans - baoquankhu1.vn
Even endpoint hits don’t spare shares in three weight-loss updates - BioCentury
Why Fractyl Health Inc. stock remains a top recommendationJuly 2025 Recap & Expert Approved Trade Ideas - mfd.ru
Market Trends: Is Fractyl Health Inc benefiting from interest rate changesJuly 2025 Sector Moves & Free Reliable Trade Execution Plans - baoquankhu1.vn
Pricey healthcare stocks with halting momentumlow momentum and high valuation (AIM:NYSE) - Seeking Alpha
Fractyl Health: Unreasonably Low Market Expectations Create A Trading Opportunity Towards 2026 Catalysts - Seeking Alpha
Why did GUTS stock plummet today despite positive gut therapy midterm study? - MSN
Analysts Offer Insights on Healthcare Companies: Fractyl Health, Inc. (GUTS), GE Healthcare Technologies Inc (GEHC) and Apogee Therapeutics (APGE) - The Globe and Mail
Fractyl Health (GUTS) Is Down 78.0% After Positive REMAIN-1 Midpoint Data And De Novo FDA PlanHas The Bull Case Changed? - Sahm
Fractyl Health Shares Fall After Morgan Stanley Downgrade - marketscreener.com
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Fractyl Health, Inc. Investigated on Behalf of InvestorsContact the DJS Law Group to Discuss Your Rights – GUTS - marketscreener.com
Institutional Owners May Take Dramatic Actions as Fractyl Health, Inc.'s (NASDAQ:GUTS) Recent 72% Drop Adds to One-year Losses - 富途牛牛
Fractyl Health Inc (GUTS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.20%
0.06%
자본화:
|
볼륨(24시간):